
HANNA – Real-world data on effectiveness and safety of Nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in Germany
Author(s) -
ChiaJung Busch,
E. von der Heyde,
Manfred Welslau,
D Hahn,
Ulrike Bockmühl,
Christine Langer,
H. Müller-Huesmann,
Thomas Gauler,
D. Waldenberger,
Andreas Dietz
Publication year - 2020
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0040-1710942
Subject(s) - tolerability , nivolumab , medicine , observational study , oncology , head and neck , quality of life (healthcare) , basal cell , adverse effect , surgery , immunotherapy , nursing , cancer